Glycaemic efficacy and safety of linagliptin compared to basal bolus insulin regimen in non-cardiac surgical patients with type 2 diabetes: Linagliptin-Surgery trial

被引：0
|
作者：
Umpierrez, G. [1 ]
Vellanki, P. [1 ]
Rasouli, N. [2 ]
Baldwin, D. [3 ]
Alexanian, S. [4 ]
Anzola, I. [1 ]
Urrutia, M. [1 ]
Gomez, P. [1 ]
Cardona, S. [1 ]
Wang, H. [1 ]
Pasquel, F. [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Univ Colorado, Med, Denver, CO 80202 USA
[3] Rush Univ, Chicago, IL 60612 USA
[4] Boston Univ, Med, Boston, MA 02215 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
769
引用
收藏
页码：S377 / S378
页数：2
相关论文
共 50 条
  • [41] Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes
    Brunetti, P.
    Muggeo, M.
    Cattin, L.
    Arcangeli, A.
    Pozzilli, P.
    Provenzano, V.
    Francesconi, A.
    Calatola, P.
    Santeusanio, F.
    DIABETOLOGIA, 2007, 50 : S394 - S394
  • [42] Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Gron, Randi
    Halladin, Natalie
    Jodar, Esteban
    DIABETES CARE, 2018, 41 (05) : 1009 - 1016
  • [43] Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes
    Philotheou, Areti
    Arslanian, Silva
    Blatniczky, Laszlo
    Peterkova, Valentina
    Souhami, Elisabeth
    Danne, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 327 - 334
  • [44] Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial
    Billings, L. K.
    Doshi, A.
    Gouet, D.
    Oviedo, A.
    Rodbard, H. W.
    Tentolouris, N.
    Gron, R.
    Halladin, N.
    Jodar, E.
    DIABETOLOGIA, 2017, 60 : S366 - S366
  • [45] Efficacy of a basal insulin titration app on glycaemic outcomes in people with type 2 diabetes on an oral-basal insulin regimen: results of an RCT
    Hermanns, N.
    Ehrmann, D.
    Groene, K. Finke
    Roos, T.
    Kulzer, B.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S417 - S417
  • [46] Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
    Inzucchi, S. E.
    Nauck, M. A.
    Hehnke, U.
    Woerle, H-J.
    von Eynatten, M.
    Henry, R. R.
    DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 868 - 877
  • [47] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [48] Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial
    Del Prato, S.
    Barnett, A. H.
    Huisman, H.
    Neubacher, D.
    Woerle, H. -J.
    Dugi, K. A.
    DIABETES OBESITY & METABOLISM, 2011, 13 (03): : 258 - 267
  • [49] Comparable pharmacodynamics, efficacy, and safety of linagliptin 5 mg among Japanese, Asian and white patients with type 2 diabetes
    Sarashina, Akiko
    Friedrich, Christian
    Crowe, Susanne
    Patel, Sanjay
    Graefe-Mody, Ulrike
    Hayashi, Naoyuki
    Horie, Yoshiharu
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (05): : 744 - 750
  • [50] A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
    Umpierrez, Guillermo E.
    Cardona, Saumeth
    Chachkhiani, David
    Fayfman, Maya
    Saiyed, Sahebi
    Wang, Heqiong
    Vellanki, Priyathama
    Haw, J. Sonya
    Olson, Darin E.
    Pasquel, Francisco J.
    Johnson, Theodore M.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2018, 19 (05) : 399 - +
12345